As of 2026-01-02, the EV/EBITDA ratio of AVITA Medical Inc (RCEL) is -3.25. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AVITA's latest enterprise value is 132.22 mil USD. AVITA's TTM EBITDA according to its financial statements is -40.73 mil USD. Dividing these 2 quantities gives us the above AVITA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.2x - 15.4x | 15.3x |
| Forward P/E multiples | 21.9x - 43.9x | 32.9x |
| Fair Price | (30.14) - (21.46) | (33.08) |
| Upside | -973.7% - -722.0% | -1058.9% |
| Date | EV/EBITDA |
| 2025-12-31 | -3.25 |
| 2025-12-30 | -3.25 |
| 2025-12-29 | -3.24 |
| 2025-12-26 | -3.24 |
| 2025-12-24 | -3.30 |
| 2025-12-23 | -3.24 |
| 2025-12-22 | -3.23 |
| 2025-12-19 | -3.25 |
| 2025-12-18 | -3.18 |
| 2025-12-17 | -3.11 |
| 2025-12-16 | -3.16 |
| 2025-12-15 | -3.21 |
| 2025-12-12 | -3.25 |
| 2025-12-11 | -3.31 |
| 2025-12-10 | -3.28 |
| 2025-12-09 | -3.31 |
| 2025-12-08 | -3.25 |
| 2025-12-05 | -3.28 |
| 2025-12-04 | -3.32 |
| 2025-12-03 | -3.29 |
| 2025-12-02 | -3.36 |
| 2025-12-01 | -3.35 |
| 2025-11-28 | -3.43 |
| 2025-11-26 | -3.59 |
| 2025-11-25 | -3.47 |
| 2025-11-24 | -3.47 |
| 2025-11-21 | -3.50 |
| 2025-11-20 | -3.54 |
| 2025-11-19 | -3.62 |
| 2025-11-18 | -3.62 |
| 2025-11-17 | -3.55 |
| 2025-11-14 | -3.47 |
| 2025-11-13 | -3.46 |
| 2025-11-12 | -3.49 |
| 2025-11-11 | -3.63 |
| 2025-11-10 | -3.64 |
| 2025-11-07 | -3.49 |
| 2025-11-06 | -3.21 |
| 2025-11-05 | -3.28 |
| 2025-11-04 | -3.37 |
| 2025-11-03 | -3.49 |
| 2025-10-31 | -3.56 |
| 2025-10-30 | -3.41 |
| 2025-10-29 | -3.43 |
| 2025-10-28 | -3.40 |
| 2025-10-27 | -3.50 |
| 2025-10-24 | -3.64 |
| 2025-10-23 | -3.67 |
| 2025-10-22 | -3.63 |
| 2025-10-21 | -3.75 |